Tuberculosis Verrucosa Cutis

Afshar, Kamyar; Mindi, Manpreet
December 2004
Mayo Clinic Proceedings;Dec2004, Vol. 79 Issue 12, p1562
Academic Journal
Reports on a case of a patient with tuberculosis verrucosa cutis. Manifestations of the condition; Treatment regimen given to the patient; Characteristics of the lesions found on the patient.


Related Articles

  • Recent advances in the control programs and therapy of leprosy. Rao, Naraslmha P. // Indian Journal of Dermatology, Venereology & Leprology;Sep/Oct2004, Vol. 70 Issue 5, p269 

    Leprosy control programs, including multi-drug therapy for leprosy, have undergone significant changes over the last few years. With the process of integration of leprosy into general health services taking place all over India, dermatologists are more responsible for the care of leprosy...

  • Comparison of two systems of classification of leprosy based on number of skin lesions and number of body areas involved -- A clinicopathological concordance study. Rao, P. Narasimha; Sujai, Suneetha; Srinivas, D.; Lakshmi, T. S. S. // Indian Journal of Dermatology, Venereology & Leprology;Jan/Feb2005, Vol. 71 Issue 1, p14 

    Background and Aims: WHO guidelines classify leprosy patients for therapeutic purposes into paucibacillary (PB) and multibacillary (MB) leprosy based on the number of skin lesions. An alternative system of classification has been in practice in Nepal from 1985 onwards, based on the number of...

  • GP Clinical: Common mycobacterial infections. Watkins, Jean // GP: General Practitioner;9/16/2005, p52 

    The article provides information on common microbial infections. A young woman was presented with a weeping, ulcerated area on the left side of her neck. Under the scrofuloderma, grossly enlarged cervical glands could be felt. Biopsy and culture of the glands confirmed the presence of...

  • Editors' Summary.  // PLoS Medicine;Feb2007, Vol. 4 Issue 2, p296 

    The article presents an editors' summary of the article "Protection against Mycobacterium ulcerans Lesion Development by Exposure to Aquatic Insect Saliva." The editors note that buruli ulcer disease is a severe skin infection caused by Mycobacterium ulcerans, a bacterium related to those that...

  • Patient and health care system delays in the start of tuberculosis treatment in Norway. Farah, Mohamed Guled; Rygh, Jens Henning; Steen, Tore W.; Selmer, Randi; Heldal, Einar; Bjune, Gunnar // BMC Infectious Diseases;2006, Vol. 6 Issue 1, p33 

    Background: Delay in start of tuberculosis (TB) treatment has an impact at both the individual level, by increasing the risk of morbidity and mortality, and at the community level, by increasing the risk of transmission. The aims of this study were to assess the delays in the start of treatment...

  • Integrating tuberculosis and HIV services. Whitelaw, A. // Southern African Journal of Epidemiology & Infection;2011, Vol. 26 Issue 2, p55 

    The tuberculosis (TB) and human immunodeficiency virus (HIV) epidemics pose huge challenges to health services in South Africa. People with HIV infection are at significantly higher risk of both TB infection and progression to active disease. There is, thus, a need to implement adequate...

  • Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases. Aiken, Alexander M; Hill, Philip C; Fox, Annette; McAdam, Keith PWJ; Jackson-Sillah, DollY; Lugos, Moses D; Donkor, Simon A; Adegbola, Richard A; and Roger H Brookes // BMC Infectious Diseases;2006, Vol. 6 Issue 1, p66 

    Background: New tools are required to improve tuberculosis (TB) diagnosis and treatment, including enhanced ability to compare new treatment strategies. The ELISPOT assay uses Mycobacterium tuberculosis-specific antigens to produce a precise quantitative readout of the immune response to...

  • Vaccines for TB: Lessons from the Past Translating into Future Potentials. Tye, Gee Jun; Lew, Min Han; Choong, Yee Siew; Lim, Theam Soon; Sarmiento, Maria Elena; Acosta, Armando; Norazmi, Mohd Nor // Journal of Immunology Research;6/3/2015, Vol. 2015, p1 

    Development of vaccines for infectious diseases has come a long way with recent advancements in adjuvant developments and discovery of new antigens that are capable of eliciting strong immunological responses for sterile eradication of disease. Tuberculosis (TB) that kills nearly 2 million of...

  • Identifying the determinants of tuberculosis control in resource-poor countries: insights from a qualitative study in The Gambia. Harper, M.; Ahmadu, F.A.; Ogden, J.A.; McAdam, K.P.; Lienhardt, C. // Transactions of the Royal Society of Tropical Medicine & Hygiene;Sep2003, Vol. 97 Issue 5, p506 

    Abstract: Despite the availability of effective treatment, tuberculosis (TB) remains a major cause of death from an infectious disease in the world, particularly in resource-poor countries. Among the chief reasons for this are deficiencies in case tracing and in adherence to treatment. In order...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics